{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,9]],"date-time":"2026-07-09T05:29:56Z","timestamp":1783574996138,"version":"3.55.0"},"reference-count":22,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2023,2,11]],"date-time":"2023-02-11T00:00:00Z","timestamp":1676073600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,2,11]],"date-time":"2023-02-11T00:00:00Z","timestamp":1676073600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ann Surg Oncol"],"published-print":{"date-parts":[[2023,5]]},"DOI":"10.1245\/s10434-022-12692-w","type":"journal-article","created":{"date-parts":[[2023,2,11]],"date-time":"2023-02-11T23:02:52Z","timestamp":1676156572000},"page":"2976-2987","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Robotic Versus Open Cystectomy for Bladder Cancer: Synthesizing the Data from Current Systematic Reviews and Meta-Analyses"],"prefix":"10.1245","volume":"30","author":[{"given":"Khatereh","family":"Aminoltejari","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amanda E.","family":"Hird","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zachary","family":"Klaassen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raj","family":"Satkunasivam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Girish S.","family":"Kulkarni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amy N.","family":"Luckenbaugh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aaron A.","family":"Laviana","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher J. D.","family":"Wallis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roderick","family":"Clark","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,2,11]]},"reference":[{"issue":"4","key":"12692_CR1","doi-asserted-by":"publisher","first-page":"408","DOI":"10.1046\/j.1464-410x.2001.00115.x","volume":"87","author":"J Binder","year":"2001","unstructured":"Binder J, Kramer W. Robotically-assisted laparoscopic radical prostatectomy. BJU Int. 2001;87(4):408\u201310. https:\/\/doi.org\/10.1046\/j.1464-410x.2001.00115.x.","journal-title":"BJU Int."},{"issue":"1","key":"12692_CR2","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1016\/j.eururo.2008.07.031","volume":"55","author":"A Shabsigh","year":"2009","unstructured":"Shabsigh A, Korets R, Vora KC, et al. Defining early morbidity of radical cystectomy for patients with bladder cancer using a standardized reporting methodology. Eur Urol. 2009;55(1):164\u201374. https:\/\/doi.org\/10.1016\/j.eururo.2008.07.031.","journal-title":"Eur Urol."},{"issue":"20","key":"12692_CR3","doi-asserted-by":"publisher","first-page":"1895","DOI":"10.1056\/NEJMoa1806395","volume":"379","author":"PT Ramirez","year":"2018","unstructured":"Ramirez PT, Frumovitz M, Pareja R, et al. Minimally invasive versus abdominal radical hysterectomy for cervical cancer. N Engl J Med. 2018;379(20):1895\u2013904. https:\/\/doi.org\/10.1056\/NEJMoa1806395.","journal-title":"N Engl J Med."},{"key":"12692_CR4","doi-asserted-by":"publisher","unstructured":"Nguyen DP, Al Hussein Al Awamlh B, Wu X, et al Recurrence patterns after open and robot-assisted radical cystectomy for bladder cancer. Eur Urol. 2015;68(3):399\u2013405 https:\/\/doi.org\/10.1016\/j.eururo.2015.02.003","DOI":"10.1016\/j.eururo.2015.02.003"},{"issue":"10139","key":"12692_CR5","doi-asserted-by":"publisher","first-page":"2525","DOI":"10.1016\/S0140-6736(18)30996-6","volume":"391","author":"DJ Parekh","year":"2018","unstructured":"Parekh DJ, Reis IM, Castle EP, et al. Robot-assisted radical cystectomy versus open radical cystectomy in patients with bladder cancer (RAZOR): an open-label randomised phase 3 non-inferiority trial. Lancet. 2018;391(10139):2525\u201336. https:\/\/doi.org\/10.1016\/S0140-6736(18)30996-6.","journal-title":"Lancet"},{"key":"12692_CR6","unstructured":"Ryan RHS. How to GRADE the quality of the evidence. Accessed January 28, 2019."},{"key":"12692_CR7","doi-asserted-by":"publisher","first-page":"j4008","DOI":"10.1136\/bmj.j4008","volume":"358","author":"BJ Shea","year":"2017","unstructured":"Shea BJ, Reeves BC, Wells G, et al. AMSTAR 2: a critical appraisal tool for systematic reviews that include randomised or non-randomised studies of healthcare interventions, or both. BMJ. 2017;358:j4008. https:\/\/doi.org\/10.1136\/bmj.j4008.","journal-title":"BMJ"},{"issue":"6","key":"12692_CR8","doi-asserted-by":"publisher","first-page":"553","DOI":"10.23736\/S0393-2249.19.03546-X","volume":"71","author":"S Albisinni","year":"2019","unstructured":"Albisinni S, Veccia A, Aoun F, et al. A systematic review and meta-analysis comparing the outcomes of open and robotic assisted radical cystectomy. Minerva Urol Nefrol. 2019;71(6):553\u201368. https:\/\/doi.org\/10.23736\/S0393-2249.19.03546-X.","journal-title":"Minerva Urol Nefrol."},{"issue":"8","key":"12692_CR9","doi-asserted-by":"publisher","first-page":"1557","DOI":"10.1007\/s00345-019-02708-8","volume":"37","author":"T Iwata","year":"2019","unstructured":"Iwata T, Kimura S, Foerster B, et al. Oncologic outcomes after robot-assisted versus open radical cystectomy: a systematic review and meta-analysis. World J Urol. 2019;37(8):1557\u201370. https:\/\/doi.org\/10.1007\/s00345-019-02708-8.","journal-title":"World J Urol."},{"issue":"8","key":"12692_CR10","doi-asserted-by":"publisher","first-page":"760","DOI":"10.1111\/iju.14005","volume":"26","author":"S Kimura","year":"2019","unstructured":"Kimura S, Iwata T, Foerster B, et al. Comparison of perioperative complications and health-related quality of life between robot-assisted and open radical cystectomy: a systematic review and meta-analysis. Int J Urol. 2019;26(8):760\u201374. https:\/\/doi.org\/10.1111\/iju.14005.","journal-title":"Int J Urol."},{"key":"12692_CR11","doi-asserted-by":"publisher","first-page":"CD001903","DOI":"10.1002\/14651858.CD011903.pub2","volume":"4","author":"BP Rai","year":"2019","unstructured":"Rai BP, Bondad J, Vasdev N, et al. Robotic versus open radical cystectomy for bladder cancer in adults. Cochrane Database Syst Rev. 2019;4:CD001903. https:\/\/doi.org\/10.1002\/14651858.CD011903.pub2.","journal-title":"Cochrane Database Syst Rev."},{"issue":"4","key":"12692_CR12","doi-asserted-by":"publisher","first-page":"715","DOI":"10.1016\/j.juro.2018.10.006","volume":"201","author":"NJ Sathianathen","year":"2019","unstructured":"Sathianathen NJ, Kalapara A, Frydenberg M, et al. Robotic assisted radical cystectomy vs open radical cystectomy: systematic review and meta-analysis. J Urol. 2019;201(4):715\u201320. https:\/\/doi.org\/10.1016\/j.juro.2018.10.006.","journal-title":"J Urol."},{"issue":"4","key":"12692_CR13","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1016\/j.euo.2018.10.008","volume":"2","author":"R Satkunasivam","year":"2019","unstructured":"Satkunasivam R, Tallman CT, Taylor JM, Miles BJ, Klaassen Z, Wallis CJD. Robot-assisted radical cystectomy versus open radical cystectomy: a meta-analysis of oncologic, perioperative, and complication-related outcomes. Eur Urol Oncol. 2019;2(4):443\u20137. https:\/\/doi.org\/10.1016\/j.euo.2018.10.008.","journal-title":"Eur Urol Oncol."},{"issue":"4","key":"12692_CR14","doi-asserted-by":"publisher","first-page":"509","DOI":"10.4293\/108680809X12589998404128","volume":"13","author":"KA Guru","year":"2009","unstructured":"Guru KA, Perlmutter AE, Butt ZM, et al. The learning curve for robot-assisted radical cystectomy. JSLS. 2009;13(4):509\u201314.","journal-title":"JSLS."},{"issue":"10049","key":"12692_CR15","doi-asserted-by":"publisher","first-page":"1057","DOI":"10.1016\/S0140-6736(16)30592-X","volume":"388","author":"JW Yaxley","year":"2016","unstructured":"Yaxley JW, Coughlin GD, Chambers SK, et al. Robot-assisted laparoscopic prostatectomy versus open radical retropubic prostatectomy: early outcomes from a randomised controlled phase 3 study. Lancet. 2016;388(10049):1057\u201366. https:\/\/doi.org\/10.1016\/S0140-6736(16)30592-X.","journal-title":"Lancet."},{"issue":"3","key":"12692_CR16","doi-asserted-by":"publisher","first-page":"522","DOI":"10.1097\/JU.0000000000000565","volume":"203","author":"V Venkatramani","year":"2020","unstructured":"Venkatramani V, Reis IM, Castle EP, et al. Predictors of recurrence, and progression-free and overall survival following open versus robotic radical cystectomy: analysis from the RAZOR trial with a 3-year followup. J Urol. 2020;203(3):522\u20139.","journal-title":"J Urol."},{"issue":"2","key":"12692_CR17","doi-asserted-by":"publisher","first-page":"e2148329","DOI":"10.1001\/jamanetworkopen.2021.48329","volume":"5","author":"V Venkatramani","year":"2022","unstructured":"Venkatramani V, Reis IM, Gonzalgo ML, et al. Comparison of robot-assisted and open radical cystectomy in recovery of patient-reported and performance-related measures of independence: a secondary analysis of a randomized clinical trial. JAMA Netw Open. 2022;5(2):e2148329. https:\/\/doi.org\/10.1001\/jamanetworkopen.2021.48329.","journal-title":"JAMA Netw Open."},{"issue":"3","key":"12692_CR18","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1007\/s11701-020-01174-4","volume":"15","author":"K Tanneru","year":"2021","unstructured":"Tanneru K, Jazayeri SB, Kumar J, et al. Intracorporeal versus extracorporeal urinary diversion following robot-assisted radical cystectomy: a meta-analysis, cumulative analysis, and systematic review. J Robot Surg. 2021;15(3):321\u201333. https:\/\/doi.org\/10.1007\/s11701-020-01174-4.","journal-title":"J Robot Surg."},{"issue":"5","key":"12692_CR19","doi-asserted-by":"publisher","first-page":"982","DOI":"10.1097\/JU.0000000000002422","volume":"207","author":"R Mastroianni","year":"2022","unstructured":"Mastroianni R, Ferriero M, Tuderti G, et al. Open radical cystectomy versus robot-assisted radical cystectomy with intracorporeal urinary diversion: early outcomes of a single-center randomized controlled trial. J Urol. 2022;207(5):982\u201392.","journal-title":"J Urol."},{"issue":"8","key":"12692_CR20","doi-asserted-by":"publisher","first-page":"e020500","DOI":"10.1136\/bmjopen-2017-020500","volume":"8","author":"JWF Catto","year":"2018","unstructured":"Catto JWF, Khetrapal P, Ambler G, et al. Robot-assisted radical cystectomy with intracorporeal urinary diversion versus open radical cystectomy (iROC): protocol for a randomised controlled trial with internal feasibility study. BMJ Open. 2018;8(8):e020500. https:\/\/doi.org\/10.1136\/bmjopen-2017-020500.","journal-title":"BMJ Open."},{"issue":"2","key":"12692_CR21","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1007\/s11934-006-0071-4","volume":"7","author":"S Kaul","year":"2006","unstructured":"Kaul S, Shah NL, Menon M. Learning curve using robotic surgery. Curr Urol Rep. 2006;7(2):125\u20139. https:\/\/doi.org\/10.1007\/s11934-006-0071-4.","journal-title":"Curr Urol Rep."},{"issue":"1","key":"12692_CR22","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1186\/s12894-019-0533-x","volume":"19","author":"Y Morii","year":"2019","unstructured":"Morii Y, Osawa T, Suzuki T, et al. Cost comparison between open radical cystectomy, laparoscopic radical cystectomy, and robot-assisted radical cystectomy for patients with bladder cancer: a systematic review of segmental costs. BMC Urol. 2019;19(1):110. https:\/\/doi.org\/10.1186\/s12894-019-0533-x.","journal-title":"BMC Urol."}],"container-title":["Annals of Surgical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1245\/s10434-022-12692-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1245\/s10434-022-12692-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1245\/s10434-022-12692-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,4,10]],"date-time":"2023-04-10T14:09:40Z","timestamp":1681135780000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1245\/s10434-022-12692-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,2,11]]},"references-count":22,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2023,5]]}},"alternative-id":["12692"],"URL":"https:\/\/doi.org\/10.1245\/s10434-022-12692-w","relation":{},"ISSN":["1068-9265","1534-4681"],"issn-type":[{"value":"1068-9265","type":"print"},{"value":"1534-4681","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,2,11]]},"assertion":[{"value":"3 May 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 October 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 February 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Girish Kulkarni, Relevant Financial Activities outside the Submitted Work. Merck, Tersera, Janssen, Astra Zeneca, BMS, Verity, Emd serono, Knight therapeutics, Bayer, Christopher Wallis Consulting Fees: Janssen Oncology, SESEN Bio, Precision Point Specialty LLC. Honoraria: Bayer, EMD Serono, Haymarket Media, Healing and Cancer Foundation, Knight Therapeutics, Tolmar Pharmaceuticals Canada.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Disclosures"}}]}}